DarioHealth (NASDAQ:DRIO) Stock Price Passes Below 200-Day Moving Average – Here’s Why

DarioHealth Corp. (NASDAQ:DRIO)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.12 and traded as low as $0.78. DarioHealth shares last traded at $0.78, with a volume of 13,390 shares traded.

DarioHealth Trading Down 1.3 %

The stock has a market cap of $26.60 million, a price-to-earnings ratio of -0.83 and a beta of 1.51. The business’s 50 day moving average is $0.95 and its 200 day moving average is $1.12. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

Institutional Trading of DarioHealth

Hedge funds have recently made changes to their positions in the company. Appian Way Asset Management LP boosted its holdings in DarioHealth by 2.5% in the 3rd quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock valued at $1,580,000 after purchasing an additional 34,990 shares in the last quarter. DLK Investment Management LLC raised its position in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after acquiring an additional 41,943 shares in the last quarter. Finally, XTX Topco Ltd lifted its holdings in DarioHealth by 81.4% in the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock valued at $33,000 after acquiring an additional 13,219 shares during the period. Institutional investors and hedge funds own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.